AI assistant
Sending…
AMGEN INC — Director's Dealing 2012
Oct 26, 2012
29819_dirs_2012-10-26_51875f0f-94bd-4cac-a681-88c980099bc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-10-25
Reporting Person: OMENN GILBERT S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-25 | Common Stock | G | 8572 | — | Disposed | 176783 | Direct |
Footnotes
F1: These shares include 108 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
More from AMGEN INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Board/Management Information
2026
May 19
Interim / Quarterly Report
2026
May 1
Earnings Release
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Board/Management Information
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7